Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield.
The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.
Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.
How Retail Design Can Improve the Healthcare Patient Experience
Jefferson Health Breaks Ground on Lehigh Valley Hospital—Coopersburg
Encompass Health Plans Second Small-Format Rehabilitation Hospital
Rethinking How Healthcare Facilities Fund Construction Projects
Winners Named for the 15th Annual Healthcare Design Awards